Log on / register
Feedback | Support | My details
Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.
Nagase H, Brew K
Arthritis Res 2002, 4 Suppl 3:S51-61
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Review
Drugs in development: bisphosphonates and metalloproteinase inhibitors
Catterall JB, Cawston TE
Arthritis Res Ther 2003, 5:12-24 (8 November 2002)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
2.
37%37%


 Review
Matrix metalloproteinases in arthritic disease
Murphy G, Knäuper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I
Arthritis Res 2002, 4(Suppl 3):S39-S49 (9 May 2002)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.